GSK plc announced the purchase of 330,000 ordinary shares at prices ranging from 2,105.00p to 2,140.00p on April 8, 2026, as part of its ongoing buyback program, totaling 17,566,521 shares bought since February 17, 2026. After this transaction, GSK holds 257,457,615 treasury shares and has 4,058,726,834 shares issued.